| 前收市價 | 102.36 |
| 開市 | 102.94 |
| 買盤 | 103.68 x 無 |
| 賣出價 | 104.08 x 無 |
| 今日波幅 | 102.94 - 103.68 |
| 52 週波幅 | 71.47 - 131.78 |
| 成交量 | |
| 平均成交量 | 147 |
| 市值 | 41.232B |
| Beta 值 (5 年，每月) | 1.16 |
| 市盈率 (最近 12 個月) | 73.01 |
| 每股盈利 (最近 12 個月) | 1.42 |
| 業績公佈日 | 2024年7月25日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 無 |
ZacksDexCom (DXCM), Abbott to Launch First FDA Cleared OTC CGMs
Dexcom (DXCM) and Abbott are set to launch their first FDA-approved over-the-counter CGMs, Stelo and Lingo & Libre Rio, respectively, in the United States this summer.
Motley Fool2 Top Growth Stocks to Buy With $1,000
These stocks have excellent track records of beating the market.
Barrons.comDid Your Heart Just Skip a Beat? Your Watch Already Knows That and More.
Smart rings and smartwatches are providing consumers with reams of health information. Clinical device makers like DexCom needn’t worry.
